top of page
Image by engin akyurt

Developing Digital Technologies for Neurodegenerative Diseases




Who We Are

At ClearSky we are passionate about improving the lives of people affected by neurodegenerative conditions. We combine the expertise of a diverse team of professionals from AI & Machine Learning, consultant clinical neurology, and seasoned pharmaceutical and MedTech industry professionals. 

Our founder, Professor Stephen Smith, is a visionary leader who has dedicated years of academic work to the application of machine learning in medical research.

ClearSky has a track record of developing devices for Parkinson’s, Huntingdon’s, and our latest research is tackling the diagnosis of dementia – find out more

What We Do

LID_patient head and torso.jpg

ClearSky offers AI/ML services for clinical research and product development in neurodegenerative conditions. With expertise in developing CE-marked medical devices and supporting global clinical studies, we are the go-to-expert in using AI and Machine Learning to address complex medical challenges.


ClearSky provides a portfolio of clinically validated non-invasive devices that offer a safe, quick, and objective assessment of patients’ symptoms, making them suitable for clinical diagnostics and supporting clinical studies.

Get in touch

The Catalyst
Baird Lane

YO10 5GA

United Kingdom

+44 (0)1904 322351


bottom of page